12 line items for aripiprazole tablets. Awarded for a base year and 4 one-year option periods.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0073
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$9,697,748.40
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026.

The contract will supply aripiprazole tablets in various package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The contract was established through a pre-solicitation notice for an unrestricted procurement, with no set-aside designation. Xlcare Pharmaceuticals is certified as an economically disadvantaged women-owned small business and has a history of providing pharmaceuticals to federal agencies, including the VA's Consolidated Mail Outpatient Pharmacy program.

Transactions

Action Obligated Date
Exercise an Option P00007 · Exercise option year 4 for aripiprazole tablets with xlcare pharmaceuticals. Period of performance is 2/1/2025 - 1/31/2026. $0
Supplemental Agreement for work within scope P00006 · Update to cost recovery fee (CRF) and submission of quarterly sales reports $0
Exercise an Option P00005 · Exercising option year 3 of 36E79720D0073 $0
Other Administrative Action P00004 · Administrative modification to add drug supply chain security act language to contract. $0
Exercise an Option P00003 · Exercising option year 2 for aripiprazole tablets without price changes. Period of performance for the 1ST option year is 02/01/2023 - 01/31/2024. $0
Exercise an Option P00002 · Exercising option year 1 for aripiprazole tablets without price changes. Period of performance for the 1ST option year is 02/01/2022 - 01/31/2023. $0
Supplemental Agreement for work within scope P00001 · 12 line item NDC changes to aripiprazole tablets for 36E79720D0073 effective on 1/12/2021 with the contract effective on 2/1/2021. $0
Original award $0

Quick answers

Who was awarded contract 36E79720D0073?

36E79720D0073 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on February 1, 2021.

How much is contract 36E79720D0073 worth?

36E79720D0073's own ceiling is $9,697,748.

Who can order from contract 36E79720D0073?

36E79720D0073 is a single award indefinite delivery contract.

Was contract 36E79720D0073 competed?

The extent of competition for 36E79720D0073 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login